Perrigo Company plc (NYSE:PRGO) Shares Sold by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC decreased its stake in Perrigo Company plc (NYSE:PRGO - Free Report) by 20.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 72,126 shares of the company's stock after selling 18,498 shares during the quarter. Janney Montgomery Scott LLC owned approximately 0.05% of Perrigo worth $2,022,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of PRGO. Headlands Technologies LLC grew its position in shares of Perrigo by 1,942.0% in the fourth quarter. Headlands Technologies LLC now owns 1,409 shares of the company's stock valued at $36,000 after purchasing an additional 1,340 shares during the period. Parallel Advisors LLC grew its position in shares of Perrigo by 176.9% in the first quarter. Parallel Advisors LLC now owns 1,714 shares of the company's stock valued at $48,000 after purchasing an additional 1,095 shares during the period. Fifth Third Bancorp grew its position in shares of Perrigo by 62.0% in the first quarter. Fifth Third Bancorp now owns 2,218 shares of the company's stock valued at $62,000 after purchasing an additional 849 shares during the period. Central Pacific Bank Trust Division grew its position in shares of Perrigo by 50.0% in the first quarter. Central Pacific Bank Trust Division now owns 3,000 shares of the company's stock valued at $84,000 after purchasing an additional 1,000 shares during the period. Finally, GAMMA Investing LLC grew its position in shares of Perrigo by 91.9% in the first quarter. GAMMA Investing LLC now owns 3,685 shares of the company's stock valued at $103,000 after purchasing an additional 1,765 shares during the period. Institutional investors and hedge funds own 95.91% of the company's stock.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded shares of Perrigo from a "hold" rating to a "buy" rating in a research report on Saturday, May 24th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $33.00.

Perrigo Stock Performance

PRGO opened at $26.62 on Friday. The firm has a market capitalization of $3.66 billion, a PE ratio of -20.32 and a beta of 0.46. Perrigo Company plc has a twelve month low of $23.14 and a twelve month high of $30.93. The firm's 50-day moving average price is $26.28 and its 200 day moving average price is $26.03. The company has a current ratio of 2.36, a quick ratio of 1.28 and a debt-to-equity ratio of 0.82.

Perrigo (NYSE:PRGO - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.60 earnings per share for the quarter, topping analysts' consensus estimates of $0.56 by $0.04. The firm had revenue of $1.04 billion for the quarter, compared to analyst estimates of $1.09 billion. Perrigo had a negative net margin of 4.16% and a positive return on equity of 8.93%. Perrigo's quarterly revenue was down 3.5% on a year-over-year basis. During the same period in the previous year, the business posted $0.29 earnings per share. As a group, sell-side analysts expect that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 17th. Stockholders of record on Friday, May 30th were paid a $0.29 dividend. The ex-dividend date was Friday, May 30th. This represents a $1.16 annualized dividend and a dividend yield of 4.36%. Perrigo's dividend payout ratio (DPR) is -88.55%.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.